Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Aslı Çiftçibaşi Örmeci"'
Autor:
Yusuf Kayar, Ramazan Dertli, Şevki Konür, Mehmet Ağın, Abdullah Al Kafee, Bülent Baran, Aslı Çiftçibaşı Örmeci, Filiz Akyüz, Kadir Demir, Fatih Beşışık, Sabahattin Kaymakoğlu
Publikováno v:
The Turkish Journal of Gastroenterology, Vol 33, Iss 11, Pp 945-954 (2022)
Externí odkaz:
https://doaj.org/article/12f6c3404785451a9a73ef601d105f99
Autor:
Tarık Onur Tiryaki, Kadir Uluç Anıl, Melek Büyük, Ahmet Yasir Yıldırım, Alp Atasoy, Aslı Çiftçibaşı Örmeci, Sevgi Kalayoğlu Beşışık
Publikováno v:
Turkish Journal of Hematology, Vol 38, Iss 2, Pp 171-173 (2021)
Externí odkaz:
https://doaj.org/article/bda9cb40c429463bbcf2e394c7a97024
Autor:
Alp Atasoy, Kadir Demir, Cetin Karaca, Selman Besisik, Bilger Cavus, Raim Iliaz, Sabahattin Kaymakoğlu, Özge Tepe, Aslı Çiftçibaşi Örmeci, Gülçin Yegen, Filiz Akyüz
Publikováno v:
Turkiye Klinikleri Journal of Internal Medicine. 6:56-61
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::220818140d5b16066eae6b6e8a25f2f0
https://doi.org/10.5336/intermed.2021-81042
https://doi.org/10.5336/intermed.2021-81042
Autor:
Mehmet Agin, Bulent Baran, Ramazan Dertli, Filiz Akyuz, Kadir Demir, Aslı Çiftçibaşi Örmeci, Fatih Besisik, Yusuf Kayar, Sabahattin Kaymakoglu, Sevki Konur
Publikováno v:
Irish Journal of Medical Science (1971 -). 190:597-604
Crohn’s disease (CD) primarily involves gastrointestinal tract; however, it can present with extraintestinal manifestations (EIMs), which leads to significant morbidity. Frequency of EIMs and associated risk factors vary due to genetic and environm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1cdb576b0bff25f45757f796e6435e03
https://doi.org/10.1007/s11845-020-02326-z
https://doi.org/10.1007/s11845-020-02326-z
Publikováno v:
Turkiye Klinikleri Journal of Case Reports. 29:157-159
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99eab14b93442b726b0ed99b66d0cdff
https://doi.org/10.5336/caserep.2021-81037
https://doi.org/10.5336/caserep.2021-81037
Autor:
Mine Gulluoglu, Filiz Akyuz, Aslı Çiftçibaşi Örmeci, Fatih Besisik, Suut Gokturk, S. Yesil, Ozlem Mutluay Soyer, C. Karaca, Sami Evirgen, Kadir Demir, Sabahattin Kaymakoglu, Bulent Baran
Publikováno v:
ResearcherID
Summary Chronic hepatitis C (CHC) patients with treatment failure (TF) remain at risk of continuing fibrosis progression. However, it has not been investigated whether there is an increased risk of accelerated fibrosis progression after failed interf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3026e152ef3cbade2ddaa06df8fa0455
https://doi.org/10.1111/jvh.12127
https://doi.org/10.1111/jvh.12127
Autor:
Fatih Besisik, Suut Gokturk, Ozlem Mutluay Soyer, Mine Gulluoglu, Sabahattin Kaymakoglu, Aslı Çiftçibaşi Örmeci, Esra Aydin, Cetin Karaca, Kadir Demir, Bulent Baran, Filiz Akyuz, Derya Onel
Publikováno v:
Postgraduate medicine. 128(4)
Interferon (IFN) therapy is associated with low rates of treatment success and high rates of recurrence in hepatitis D virus (HDV) infection. Several strategies to increase efficacy, including extending the treatment duration, have been tested. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9790967f2e5fe8741d3f80e2b6bddf16
https://pubmed.ncbi.nlm.nih.gov/27054544
https://pubmed.ncbi.nlm.nih.gov/27054544
Publikováno v:
Current Medical Research and Opinion. 33:55-56
Interferons (IFN) are cytokines with antiviral, immunomodulatory, and anti-proliferative effects and they are widely used in viral hepatitis and malignancies such as chronic myeloid leukemia, malig...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b70042f8004754238e3efabc47b2d30
https://doi.org/10.1080/03007995.2016.1233100
https://doi.org/10.1080/03007995.2016.1233100
Autor:
Sami Evirgen, Aslı Çiftçibaşi Örmeci, Kadir Demir, Arzu Poyanli, Suut Gokturk, Fatih Besisik, Filiz Akyuz, Bulent Baran, Omer Ekinci, C. Karaca, Sabahattin Kaymakoglu, Mine Gulluoglu, Ozlem Mutluay Soyer
Publikováno v:
Journal of Hepatology. 64:S321-S322
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ffbe5ad92db7aed3ae11c623b5396925
https://doi.org/10.1016/s0168-8278(16)00439-6
https://doi.org/10.1016/s0168-8278(16)00439-6
Autor:
Ozlem Mutluay Soyer, Filiz Akyuz, Kadir Demir, Sabahattin Kaymakoglu, Suut Gokturk, Fatih Besisik, Cetin Karaca, Bulent Baran, Pinar Firat, Sami Evirgen, Rafet Basar, Davut Sahin, Aslı Çiftçibaşi Örmeci
Publikováno v:
Medicine. 96:e5513
BACKGROUND Management of pancreatic cysts is based on neoplastic-nonneoplastic discrimination. Endoscopic ultrasound (EUS) enables to differentiate neoplastic-nonneoplastic lesions and also allows fine-needle aspiration (FNA). In this study, we aim t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1de2985e94f7fa8b6bd8a905278052f8
https://doi.org/10.1097/md.0000000000005513
https://doi.org/10.1097/md.0000000000005513